Decreased bioavailability of nitric oxide (NO) is one of the causes of endothelial dysfunction, which could theoretically be a consequence of decreased activity or expression of endothelial nitric oxide synthase (eNOS) and excessive NO degradation [11]. The gene discussed is NOS3; the disease is endothelial dysfunction.